このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Neuland Laboratories マネジメント
マネジメント 基準チェック /24
Neuland Laboratories'の CEO はDavuluri Raoで、 Aug2013年に任命され、 の在任期間は 10.83年です。 の年間総報酬は₹ 57.50Mで、 34.5%給与と65.5%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の3.3%を直接所有しており、その価値は₹ 2.75B 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と9.1年です。
主要情報
Davuluri Rao
最高経営責任者
₹57.5m
報酬総額
CEO給与比率 | 34.5% |
CEO在任期間 | 10.8yrs |
CEOの所有権 | 3.3% |
経営陣の平均在職期間 | 3.8yrs |
取締役会の平均在任期間 | 9.1yrs |
経営陣の近況
Recent updates
Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's
Jun 19Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?
Jun 12Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00
May 21There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet
Mar 15Can You Imagine How Elated Neuland Laboratories' (NSE:NEULANDLAB) Shareholders Feel About Its 391% Share Price Gain?
Feb 28Don't Ignore The Fact That This Insider Just Sold Some Shares In Neuland Laboratories Limited (NSE:NEULANDLAB)
Feb 12Neuland Laboratories Limited (NSE:NEULANDLAB) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 04Neuland Laboratories Limited's (NSE:NEULANDLAB) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Feb 03CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Mar 31 2024 | n/a | n/a | ₹3b |
Dec 31 2023 | n/a | n/a | ₹3b |
Sep 30 2023 | n/a | n/a | ₹3b |
Jun 30 2023 | n/a | n/a | ₹2b |
Mar 31 2023 | ₹58m | ₹20m | ₹2b |
Dec 31 2022 | n/a | n/a | ₹1b |
Sep 30 2022 | n/a | n/a | ₹831m |
Jun 30 2022 | n/a | n/a | ₹651m |
Mar 31 2022 | ₹30m | ₹15m | ₹638m |
Dec 31 2021 | n/a | n/a | ₹593m |
Sep 30 2021 | n/a | n/a | ₹731m |
Jun 30 2021 | n/a | n/a | ₹742m |
Mar 31 2021 | ₹34m | ₹11m | ₹806m |
Dec 31 2020 | n/a | n/a | ₹540m |
Sep 30 2020 | n/a | n/a | ₹384m |
Jun 30 2020 | n/a | n/a | ₹257m |
Mar 31 2020 | ₹22m | ₹10m | ₹162m |
Dec 31 2019 | n/a | n/a | ₹321m |
Sep 30 2019 | n/a | n/a | ₹257m |
Jun 30 2019 | n/a | n/a | ₹216m |
Mar 31 2019 | ₹13m | ₹10m | ₹164m |
Mar 31 2018 | ₹5m |